China’s Biotech Boom is Rewriting Global Science as NIH Crackdown Disrupts Collaborations
China’s growing biotech industry is reshaping global research while NIH restrictions on foreign funding hinder international scientific partnerships.
China’s biotech sector is expanding at a rapid pace and fundamentally changing the international research landscape, according to STAT News. At the same time, an NIH crackdown on foreign grants is disrupting long-standing global science collaborations that have powered much of health and wellness research. Full story available at https://www.statnews.com/2026/03/27/china-biotech-boom-nih-crackdown-foreign-grants-readout-newsletter/.
VITALIS: This could mean ordinary people get access to new treatments and wellness tools faster thanks to China’s surge, but the drop in global teamwork might slow down some breakthroughs we’ve come to expect from scientists working across borders.
Sources (1)
- [1]STAT+: China’s biotech boom is rewriting everything(https://www.statnews.com/2026/03/27/china-biotech-boom-nih-crackdown-foreign-grants-readout-newsletter/?utm_campaign=rss)